1-ethyl-3-(5-nitro-1,3-thiazol-2-yl)urea

Names

[ CAS No. ]:
139-94-6

[ Name ]:
1-ethyl-3-(5-nitro-1,3-thiazol-2-yl)urea

[Synonym ]:
N-ethyl-N'-(5-nitro-thiazol-2-yl)-urea
1-Ethyl-3-(5-nitrothiazol-2-yl)urea
Hepzide 30
N-Aethyl-N'-(5-nitro-thiazol-2-yl)-harnstoff
EINECS 205-387-1
Nithiazide
Nithiazid
1-Ethyl-3-(5-nitro-2-thiazolyl)harnstoff
Hepzide

Chemical & Physical Properties

[ Density]:
1.518g/cm3

[ Melting Point ]:
228ºC

[ Molecular Formula ]:
C6H8N4O3S

[ Molecular Weight ]:
216.21800

[ Exact Mass ]:
216.03200

[ PSA ]:
128.08000

[ LogP ]:
2.17980

[ Index of Refraction ]:
1.647

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YT3500000
CHEMICAL NAME :
Urea, 1-ethyl-3-(5-nitro-2-thiazolyl)-
CAS REGISTRY NUMBER :
139-94-6
BEILSTEIN REFERENCE NO. :
0218168
LAST UPDATED :
199612
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C6-H8-N4-O3-S
MOLECULAR WEIGHT :
216.24
WISWESSER LINE NOTATION :
T5N CSJ BMVM2 ENW

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
41 gm/kg/94W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
395 gm/kg/94W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors

MUTATION DATA

TYPE OF TEST :
Mutation in microorganisms
TEST SYSTEM :
Bacteria - Salmonella typhimurium
DOSE/DURATION :
75 ug/plate
REFERENCE :
ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. Volume(issue)/page/year: 5(Suppl 1),3,1983 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 31,179,1983 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 31,179,1983 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987

Safety Information

[ HS Code ]:
2934100090

Precursor & DownStream

Precursor

DownStream

  • Acetamide,2-[[(ethylamino)carbonyl](5-nitro-2-thiazolyl)amino]-
  • 2-[ethylcarbamoyl-(5-nitro-1,3-thiazol-2-yl)amino]-N-methyl-acetamide
  • 2-[(2Z)-2-(ethylcarbamoylimino)-5-nitro-1,3-thiazol-3-yl]-N,N-dipropyl-acetamide
  • (1Z)-3-ethyl-1-[5-nitro-3-[2-oxo-2-(1-piperidyl)ethyl]-1,3-thiazol-2-ylidene]urea
  • ethyl N-[2-[(2Z)-2-(ethylcarbamoylimino)-5-nitro-1,3-thiazol-3-yl]acetyl]-N-methyl-carbamate

Customs

[ HS Code ]: 2934100090

[ Summary ]:
2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%


Related Compounds

  • 1-(2-chloroethyl)-3-(5-nitro-1,3-thiazol-2-yl)urea
  • 1-(4-methylphenyl)sulfonyl-3-(5-nitro-1,3-thiazol-2-yl)urea
  • AR-A014418
  • 1-nitroso-3-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one
  • 1-methyl-3-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one
  • 1-acetyl-3-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 1-Amino-2-(3,5-dimethoxypyridin-4-yl)propan-2-ol
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide